undefined
The trademark application was filed by Astellas Pharma Inc., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on May 4, 2023, and it was registered by office on August 11, 2023 without any oppositions.
The application was filed in English (Spanish was selected as the second language).